Aripiprazole prevents from development of vincristine-induced neuropathic nociception by limiting neural NOS overexpression and NF-kB hyperactivation.
Mina KhalilzadehFereshteh HassanzadehHelia AghamiriAhmad Reza DehpourHamed ShafaroodiPublished in: Cancer chemotherapy and pharmacology (2020)
In conclusion, aripiprazole effectively prevents from vincristine-induced neuropathy by limiting nNOS overexpression and NF-kB hyperactivation.